Van der Kolk discusses the long-term outlook of MDMA in patients with PTSD and what further outcomes he'd like to see explored in the space.
Part 1 of our interview with van der Kolk: • Bessel van der Kolk, M...
-------
Stay tuned for HCPLive's day-long coverage of the FDA Psychopharmacologic Drugs Advisory Committee meeting on Tuesday, June 6 at HCPLive.com.
And join us for a livestream interview with Franklin King, MD, Psychiatrist and Instructor at Mass General Hospital and Harvard Medical School!
Set your reminder here: kzread.info6tjnFxnkqSc